NCT04149002

Brief Summary

The purpose of this study is to pilot an intervention that was developed to improve uptake and adhere to an Individualized Prematurity Prevention Plan (IP3) for preterm birth prevention. Non-Hispanic Black (NHB) women are at higher risk for preterm birth compared to other racial and ethnic groups. Building on qualitative data from NHB women with input from a multidisciplinary stakeholder group, a patient-centered intervention was developed to improve uptake and adherence to an IP3 in NHB women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 11, 2019

Completed
24 days until next milestone

First Posted

Study publicly available on registry

November 4, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

February 1, 2020

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2021

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

November 2, 2022

Completed
Last Updated

November 2, 2022

Status Verified

November 1, 2022

Enrollment Period

1.2 years

First QC Date

October 11, 2019

Results QC Date

March 31, 2022

Last Update Submit

November 1, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Feasibility as Measured by Number of Recruited Eligible Patients Enrolled

    Enrollment target of 30% of eligible patients recruited.

    study duration (approximately 14 months)

  • Acceptability as Measured by Number of Participants Who Completed the Study

    Completion target of 80% participants retained in study protocol.

    study duration (approximately 14 months)

Secondary Outcomes (10)

  • IP3 Adherence as Measured by Number of Participants With Patient and EMR (Electronic Medical Record) Report of Medication Compliance

    approximately 1 year

  • Pregnancy Specific Anxiety (PSA)

    baseline, 28 weeks

  • Interpersonal Process of Care (IPC-18) at Protocol Completion - Communication Domain

    protocol completion (approximately 1 year)

  • Interpersonal Process of Care (IPC-18) at Protocol Completion - Decision Making Domain

    protocol completion (approximately 1 year)

  • Interpersonal Process of Care (IPC-18) at Protocol Completion - Interpersonal Style Domain

    protocol completion (approximately 1 year)

  • +5 more secondary outcomes

Study Arms (2)

Intervention Arm: Weekly IP3 text messages

OTHER

* A narrated powerpoint presentation describing the logistical details and medical rationale for components of the IP3. Participants will view the chapters of the presentation that are relevant to their specific IP3. There are a total of 4 possible chapters (lifestyle modifications, cervix length screening/cerclage, progesterone therapy, low dose aspirin). Each chapter of the presentation is \~ 10 - 15 min in length. Each chapter also includes a 4- 5 questions pre-test and the same questions are delivered as a post-test after the presentation. * Print materials including a letter explaining the importance of prenatal care for preterm birth prevention to employers. * Text messages sent weekly to encourage the patient to continue with their IP3 and provide basic pregnancy information * Formal letter of encouragement from provider at 28 weeks gestation

Behavioral: Intervention Arm Weekly IP3 text messages

Control Arm: General pregnancy text messages

ACTIVE COMPARATOR

* a pre-intervention questionnaire * a narrated powerpoint with general information about the clinic * a post-presentation questionnaire * text messages sent approximately weekly with general pregnancy information (e.g. today your baby is about the size of an apple) * an exit interview

Other: Active Control Arm General pregnancy text messages

Interventions

Subjects will be provided with a pre and post intervention survey, in addition to a narrated Powerpoint presentation focusing on the logistics of their IP3. Subjects will also receive weekly automated text messages to encourage adherence to the need for their IP3.

Intervention Arm: Weekly IP3 text messages

Subjects will be given pre and post pre questionnaires, in addition to a narrated Powerpoint presentation about the Clinic. Subjects will also be sent weekly text messages with general pregnancy information.

Control Arm: General pregnancy text messages

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • self described race as Non-Hispanic Black
  • history of prior singleton preterm delivery (before 37 weeks gestation)
  • current singleton gestation

You may not qualify if:

  • women with anomalous fetuses
  • age below 18\]
  • non-English speaking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University

Durham, North Carolina, 27705, United States

Location

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Results Point of Contact

Title
Sarahn M. Wheeler, MD
Organization
Duke University

Study Officials

  • Sarahn Wheeler, MD

    Duke University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Intervention Arm vs. Active Control Arm
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 11, 2019

First Posted

November 4, 2019

Study Start

February 1, 2020

Primary Completion

April 1, 2021

Study Completion

April 1, 2021

Last Updated

November 2, 2022

Results First Posted

November 2, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations